Medicines New Zealand - Latest News [Page 1]

Rationing medicines by stealth with budget announcement

Thursday, 17 May 2018, 5:30 pm | Medicines New Zealand

Big expectations from the Government today as it increases the pressure on PHARMAC to perform with its savings model. More >>

230,000 patients have inequitable access to modern medicines

Thursday, 19 April 2018, 11:37 am | Medicines New Zealand

More than 230,000 New Zealand patients are deprived from accessing a range of modern medicines shown by the latest information published in New Zealand’s Medicines Landscape. More >>

NZ research influences international treatment for gout

Thursday, 15 February 2018, 9:50 am | Medicines New Zealand

Otago University’s Professor Lisa Stamp will receive the Medicines New Zealand 2017 Value of Medicines Award tonight for her breakthrough research into gout. Her research was the first randomized controlled trial to demonstrate an improved dosing ... More >>

Equitable access to breakthrough medicines needed

Thursday, 1 February 2018, 3:14 pm | Medicines New Zealand

Former clinical leader, Dr. Lee Mathias, has been appointed as new chair for Medicines New Zealand the industry association for the biopharmaceutical presence in New Zealand. More >>

Medicines New Zealand seeks independent chair for 2018

Monday, 13 November 2017, 3:49 pm | Medicines New Zealand

Medicines New Zealand independent Chair, Hon. Heather Roy has announced she is leaving the role after representing the Pharmaceutical industry for six years. More >>

Researchers succeed after the Value of Medicines Award

Monday, 21 August 2017, 3:30 pm | Medicines New Zealand

The Value of Medicines Award recognises research that improves the understanding, effectiveness or safety of the use of medicines in New Zealand and applications for the $20,000 award are open until 6th October 2017. More >>

Recognising Research Excellence: Value Of Medicines Award

Monday, 31 July 2017, 3:28 pm | Medicines New Zealand

Applications are now open for the Medicines New Zealand 2017 Value of Medicines Award. The award recognises research that improves the understanding, effectiveness or safety of the use of medicines in New Zealand. More >>

Founder of HPV Vaccine guest of honour at Parliament

Wednesday, 21 June 2017, 3:23 pm | Medicines New Zealand

Founder of HPV Vaccine guest of honour at Parliamentary Dinner. Professor Ian Frazer founder of the HPV vaccine is the guest speaker at the Medicines New Zealand Parliamentary dinner this evening, hosted at Parliament by the Chair of Health Committee, Simon ... More >>

Red carpet for inventor of world’s first cancer vaccine

Monday, 19 June 2017, 4:18 pm | Medicines New Zealand

NZ rolls out red carpet for inventor of world’s first cancer vaccine. Pioneering Australian researcher and 2006 Australian of the Year, Professor Ian Frazer, is paying a short visit to New Zealand this week. He is a guest of honour at the Medicines ... More >>

Patient Voice Prompts New Medicines Funding

Sunday, 7 May 2017, 8:33 pm | Medicines New Zealand

Medicines New Zealand is pleased that the New Zealand Government has today announced an additional investment of $60 million towards new medicines. More >>

Medicines in New Zealand are overlooked and underfunded

Friday, 5 May 2017, 9:15 am | Medicines New Zealand

Medicines New Zealand today released their latest Annual Report, The New Zealand Medicines Landscape 2016. It reveals patients in New Zealand are at the end of the queue for cost-effective, innovative medicines compared with other countries. More >>

Paracetamol wins Wellington researchers $20,000 prize

Monday, 10 October 2016, 9:48 am | Medicines New Zealand

Dr Paul Young will be presented with Medicines New Zealand’s 2016 Value of Medicines Award for leading a world-class study into the effects paracetamol has on patients in intensive care units (ICU) this evening. More >>

Research shows new cancer medicines pay for themselves

Tuesday, 23 August 2016, 4:06 pm | Medicines New Zealand

Research by prominent American economist, Professor Frank Lichtenberg, proves New Zealand’s investment in cancer medicines reduces hospital spending, contributes to improved survival rates and decreases premature mortality rates. More >>

Economist visits NZ to present cancer research

Monday, 22 August 2016, 10:54 am | Medicines New Zealand

Renowned American economist, Professor Frank Lichtenberg, has been commissioned by Medicines New Zealand to analyse the impact new cancer medicines have on New Zealand patients and the healthcare system. More >>

Value of Medicines Award is now Open

Monday, 1 August 2016, 1:33 pm | Medicines New Zealand

Applications for the 2016 Value of Medicines Award are open for medical researchers and clinicians More >>

Medicines New Zealand Welcomes Investment Announcement

Wednesday, 4 May 2016, 1:39 pm | Medicines New Zealand

“New Zealanders have been waiting for 81 medicines recommended by PHARMAC’s pharmacology technical advisory committee (PTAC) for up to twelve years and it is pleasing that the Government is addressing this” said Hon Heather Roy, Medicines New Zealand ... More >>

Medicines New Zealand has never threatened New Zealand

Tuesday, 26 April 2016, 4:44 pm | Medicines New Zealand

Recent statements in the media misrepresent the Medicines New Zealand position on the Trans-Pacific Partnership and are not helpful to New Zealanders waiting for better access to innovative medicines. “Medicines New Zealand has never threatened New ... More >>

New Zealanders missing out on innovative medicines

Tuesday, 1 March 2016, 11:47 am | Medicines New Zealand

“We are outraged that the Minister of Health has today confirmed $30 million of PHARMAC’s budget was not reinvested in medicines in 2015. PHARMAC’s gross underfunding has left New Zealanders missing out on innovative medicines.” said Dr Graeme Jarvis, ... More >>

It’s time to treat patients - not ask for patience

Wednesday, 9 December 2015, 11:47 am | Medicines New Zealand

New Zealanders are waiting for over 35 cost-effective medicines recommended by PHARMAC’s technical advisory committee. The average waiting time is now over 3 years. “Accessing the right medicines at the right time is crucial. The reality is that New Zealanders ... More >>

Trans-Pacific Partnership: A Mixed Bag for NZ Patients

Friday, 6 November 2015, 2:51 pm | Medicines New Zealand

Medicines New Zealand believes that strong intellectual property protections are necessary for the discovery and development of new treatments and therapies for New Zealand patients, including innovative biologic medicines. “The limitation placed ... More >>

 

 

InfoPages Links

 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL